Several proteins involved in carcinogenesis or leukemogenesis are increased for clinical responders (ANO6, CHI3L1, CTSG, ELANE and FGR), suggesting that the sensitivity to ATRA/VP additionally depends on more general functions involved in cancer development. The gene discussed is ELANE; the disease is cancer.